IBDEI0XH ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16529,1,5,0)
 ;;=5^Contraceptive counseling
 ;;^UTILITY(U,$J,358.3,16529,2)
 ;;=^87608
 ;;^UTILITY(U,$J,358.3,16530,0)
 ;;=V25.9^^92^939^15
 ;;^UTILITY(U,$J,358.3,16530,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16530,1,4,0)
 ;;=4^V25.9
 ;;^UTILITY(U,$J,358.3,16530,1,5,0)
 ;;=5^Contraceptive management
 ;;^UTILITY(U,$J,358.3,16530,2)
 ;;=^276356
 ;;^UTILITY(U,$J,358.3,16531,0)
 ;;=620.2^^92^939^37
 ;;^UTILITY(U,$J,358.3,16531,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16531,1,4,0)
 ;;=4^620.2
 ;;^UTILITY(U,$J,358.3,16531,1,5,0)
 ;;=5^Ovarian Cyst
 ;;^UTILITY(U,$J,358.3,16531,2)
 ;;=Ovarian Cyst^87319
 ;;^UTILITY(U,$J,358.3,16532,0)
 ;;=595.9^^92^939^16
 ;;^UTILITY(U,$J,358.3,16532,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16532,1,4,0)
 ;;=4^595.9
 ;;^UTILITY(U,$J,358.3,16532,1,5,0)
 ;;=5^Cystitis, Unspec
 ;;^UTILITY(U,$J,358.3,16532,2)
 ;;=Cystitis, Unspec^30304
 ;;^UTILITY(U,$J,358.3,16533,0)
 ;;=626.8^^92^939^17
 ;;^UTILITY(U,$J,358.3,16533,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16533,1,4,0)
 ;;=4^626.8
 ;;^UTILITY(U,$J,358.3,16533,1,5,0)
 ;;=5^Dysfunctional uterine bleeding
 ;;^UTILITY(U,$J,358.3,16533,2)
 ;;=^87521
 ;;^UTILITY(U,$J,358.3,16534,0)
 ;;=625.3^^92^939^18
 ;;^UTILITY(U,$J,358.3,16534,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16534,1,4,0)
 ;;=4^625.3
 ;;^UTILITY(U,$J,358.3,16534,1,5,0)
 ;;=5^Dysmenorrhea
 ;;^UTILITY(U,$J,358.3,16534,2)
 ;;=Dysmenorrhea^37592
 ;;^UTILITY(U,$J,358.3,16535,0)
 ;;=625.0^^92^939^19
 ;;^UTILITY(U,$J,358.3,16535,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16535,1,4,0)
 ;;=4^625.0
 ;;^UTILITY(U,$J,358.3,16535,1,5,0)
 ;;=5^Dyspareunia
 ;;^UTILITY(U,$J,358.3,16535,2)
 ;;=Dyspareunia^37604
 ;;^UTILITY(U,$J,358.3,16536,0)
 ;;=788.1^^92^939^20
 ;;^UTILITY(U,$J,358.3,16536,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16536,1,4,0)
 ;;=4^788.1
 ;;^UTILITY(U,$J,358.3,16536,1,5,0)
 ;;=5^Dysuria
 ;;^UTILITY(U,$J,358.3,16536,2)
 ;;=Dysuria^37716
 ;;^UTILITY(U,$J,358.3,16537,0)
 ;;=621.0^^92^939^21
 ;;^UTILITY(U,$J,358.3,16537,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16537,1,4,0)
 ;;=4^621.0
 ;;^UTILITY(U,$J,358.3,16537,1,5,0)
 ;;=5^Endometrial Polyps
 ;;^UTILITY(U,$J,358.3,16537,2)
 ;;=^270517
 ;;^UTILITY(U,$J,358.3,16538,0)
 ;;=617.9^^92^939^22
 ;;^UTILITY(U,$J,358.3,16538,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16538,1,4,0)
 ;;=4^617.9
 ;;^UTILITY(U,$J,358.3,16538,1,5,0)
 ;;=5^Endometriosis, site unsp
 ;;^UTILITY(U,$J,358.3,16538,2)
 ;;=^40463
 ;;^UTILITY(U,$J,358.3,16539,0)
 ;;=054.71^^92^939^24
 ;;^UTILITY(U,$J,358.3,16539,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16539,1,4,0)
 ;;=4^054.71
 ;;^UTILITY(U,$J,358.3,16539,1,5,0)
 ;;=5^Herpes simplex of vulva
 ;;^UTILITY(U,$J,358.3,16539,2)
 ;;=^266574
 ;;^UTILITY(U,$J,358.3,16540,0)
 ;;=704.1^^92^939^25
 ;;^UTILITY(U,$J,358.3,16540,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16540,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,16540,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,16540,2)
 ;;=Hirsutism^57407
 ;;^UTILITY(U,$J,358.3,16541,0)
 ;;=V07.4^^92^939^26
 ;;^UTILITY(U,$J,358.3,16541,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16541,1,4,0)
 ;;=4^V07.4
 ;;^UTILITY(U,$J,358.3,16541,1,5,0)
 ;;=5^Hormone replacement therapy
 ;;^UTILITY(U,$J,358.3,16541,2)
 ;;=^295199
 ;;^UTILITY(U,$J,358.3,16542,0)
 ;;=625.6^^92^939^28
 ;;^UTILITY(U,$J,358.3,16542,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16542,1,4,0)
 ;;=4^625.6
 ;;^UTILITY(U,$J,358.3,16542,1,5,0)
 ;;=5^Incontinence, stress
 ;;^UTILITY(U,$J,358.3,16542,2)
 ;;=^114717
 ;;^UTILITY(U,$J,358.3,16543,0)
 ;;=628.9^^92^939^29
